NanJing First Pharmaceutical Co., Ltd. (NanJing First Pharmaceutical Co., Ltd.)

概览

关联

46

项与 NanJing First Pharmaceutical Co., Ltd. 相关的临床试验

A single-center randomized controlled study of Vonoprazan based dual therapy and Rabeprazole based dual therapy for Helicobacter pylori infection.

开始日期2023-11-20

申办/合作机构

NanJing First Pharmaceutical Co., Ltd.

ChiCTR2300072784 / Suspended早期临床1期

Correlation between time interval after gastric emptying with ultrasound assessment and quality of bowel cleansing in patients undergoing painless colonoscopy: a randomized, prospective,controlled trial

开始日期2023-07-01

申办/合作机构

NanJing First Pharmaceutical Co., Ltd.

ChiCTR2300072620 / Recruiting临床3期

A randomized, double-blind, placebo-controlled clinical study for 52 weeks to evaluate the effect of recombinant anti human GLP-1 receptor humanized monoclonal antibody injection on blood glucose fluctuation and bone metabolism in patients with type 2 diabetes

开始日期2023-07-01

申办/合作机构

NanJing First Pharmaceutical Co., Ltd.

100 项与 NanJing First Pharmaceutical Co., Ltd. 相关的临床结果

登录后查看更多信息

0 项与 NanJing First Pharmaceutical Co., Ltd. 相关的专利（医药）

登录后查看更多信息

100 项与 NanJing First Pharmaceutical Co., Ltd. 相关的药物交易

登录后查看更多信息

100 项与 NanJing First Pharmaceutical Co., Ltd. 相关的转化医学

登录后查看更多信息